No surrogate; the clinical compound (free base) was tested
“Subsequently, the tosylate salt formulation was replaced with a free base form of crinecerfont for evaluation in the pivotal chronic toxicology, carcinogenicity, prenatal and postnatal and juvenile nonclinical studies, and for the clinical studies.”